pharmacycanada-rxedtop

Reven’s Patented, First-in-Class Anti-inflammatory Treatment Platform for Sepsis on Track for Clinical Testing in COVID-19 Patients | News

GOLDEN, Colo.–(BUSINESS WIRE)–Sep 14, 2020– Reven Holdings, Inc. (“Reven”) is a privately held clinical stage biotechnology…